当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析 - 资产负债表

新华制药

(000756)

  

流通市值:74.43亿  总市值:113.42亿
流通股本:4.48亿   总股本:6.82亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金918,334,462.29824,281,588.71979,173,294.29863,701,058.02
应收票据及应收账款708,069,058.14905,293,252.81,000,952,789.571,042,363,242.74
其中:应收票据8,191,109.237,112,097.437,595,862.2516,102,635.79
应收账款699,877,948.91898,181,155.37993,356,927.321,026,260,606.95
应收款项融资240,274,709.86177,422,000.04163,211,566.07154,109,005.46
预付款项35,369,251.0268,708,549.7430,354,723.4362,495,189.81
其他应收款合计9,336,085.48,962,680.179,909,964.5910,941,914.92
应收股利--3,065,761.6-
存货1,312,983,676.75970,747,715.81,010,804,447.12969,460,174.28
合同资产819,429.42,081,627.91,782,427.91,721,856.82
其他流动资产89,146,943.1568,718,671.8839,000,092.4131,518,959.71
流动资产平衡项目0000
流动资产合计3,314,333,616.013,026,216,087.043,235,189,305.383,136,311,401.76
非流动资产:
长期股权投资58,572,09858,677,760.657,275,078.2657,232,517.6
其他权益工具投资182,797,067.3208,292,123.95195,570,891.95192,070,260.02
投资性房地产33,908,633.7334,030,125.0834,875,521.1247,210,001.26
固定资产3,325,944,627.933,297,312,343.883,271,442,816.643,368,452,767.55
在建工程730,545,057.96689,276,333.48705,962,107.58621,427,525.46
使用权资产4,324,321.344,701,414.825,387,376.185,943,821.37
无形资产494,937,199.11464,921,066.55463,364,575.68467,720,602.99
长期待摊费用14,462,413.5115,072,215.487,224,226.527,896,124.63
递延所得税资产23,478,171.1119,941,983.2818,761,824.5628,110,217.67
其他非流动资产102,863,124.9103,375,629.3280,530,857.8644,274,675.53
非流动资产平衡项目0000
非流动资产合计4,971,832,714.894,895,600,996.444,840,395,276.354,840,338,514.08
资产平衡项目0000
资产总计8,286,166,330.97,921,817,083.488,075,584,581.737,976,649,915.84
流动负债:
短期借款283,958,677.68269,315,718.39243,494,933.55233,127,580.96
应付票据及应付账款1,177,843,465.04969,968,754.231,150,295,397.481,086,235,961.84
其中:应付票据511,430,531.37439,093,244.21472,357,160.33523,539,266.83
应付账款666,412,933.67530,875,510.02677,938,237.15562,696,695.01
合同负债149,135,948.6284,177,17695,400,657.9289,138,470.63
应付职工薪酬123,985,296.7380,587,141.9591,359,103.01108,230,824.02
应交税费18,865,677.9632,926,927.9532,441,793.5254,589,332.88
其他应付款合计435,525,634.82451,718,306.2570,679,759.59490,347,496.38
应付股利15,290,599.5315,290,599.53150,227,166.535,310,599.53
一年内到期的非流动负债273,755,184.03284,327,321.23284,338,656.854,795,430.95
其他流动负债22,930,593.5112,510,163.0214,208,834.7420,424,891.69
流动负债平衡项目0000
流动负债合计2,486,000,478.392,185,531,508.972,482,219,136.612,136,889,989.35
非流动负债:
长期借款799,400,000800,900,000804,985,266.91,047,370,534.19
租赁负债1,578,792.871,729,263.482,073,041.412,111,520.84
长期应付款20,000,00020,000,00020,000,00020,000,000
递延收益100,666,757.92105,183,454.14109,733,483.64112,700,363.12
递延所得税负债99,205,514.96103,803,565.35102,833,288.81104,383,682.06
其他非流动负债3,561,5003,561,5003,561,5003,561,500
非流动负债平衡项目0000
非流动负债合计1,024,412,565.751,035,177,782.971,043,186,580.761,290,127,600.21
负债平衡项目0000
负债合计3,510,413,044.143,220,709,291.943,525,405,717.373,427,017,589.56
所有者权益(或股东权益):
实收资本(或股本)674,682,835674,682,835674,682,835673,887,535
资本公积1,055,010,870.761,061,735,223.531,048,054,337.571,030,826,413.61
其他综合收益113,618,002.82135,997,522.12125,473,695.32120,017,532.41
专项储备3,392,612.674,917,407.862,723,387.892,616,706.91
盈余公积400,960,654.39356,955,596.1356,955,596.1356,955,596.1
未分配利润2,305,438,893.922,245,086,135.312,122,924,920.242,139,658,147.75
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,553,103,869.564,479,374,719.924,330,814,772.124,323,961,931.78
少数股东权益222,649,417.2221,733,071.62219,364,092.24225,670,394.5
股东权益平衡项目0000
股东权益合计4,775,753,286.764,701,107,791.544,550,178,864.364,549,632,326.28
负债和股东权益合计8,286,166,330.97,921,817,083.488,075,584,581.737,976,649,915.84
公告日期2024-03-292023-10-282023-08-252023-04-21
审计意见(境内)标准无保留意见
TOP↑